___

Gray D. The treatment of cholesteatoma in children. Proceedings of the Royal Society of Medicine, London, 1964;57: 769-771

Osma C, Cureoglu S, Hosoglu S. The complications of chronic otitis media: report of 93 cases. J Laryngol Otol 2000;114:97-100

Sennaroglu L, Sozeri B. Otogenic brain abscess: review of 41 cases. Otolarygol Head Neck Surg 2000;123:751-755

Yetiser S, Tosun F, Kazkayasi M. Facial nevre paralysis due to chronic otitis media. Otol Neurotol 2002;23:580-588

Sade J. Middle ear mucosa. Arch Otolaryngol 1966;84:137

Jansen C. Posterior tympanotomy: access to the middle ear with preservation of the external ear canal. Arch Klin Exp Ohren Kehlkopfheilkd 1967;188:558-9

Sheehy JL, Patterson MR. Intact canal wall tympanoplasty with mastoidectomy. A review of eight years’ experience. Laryngoscope 1967;77:1502-1542

Portmann M. Open or closed technique in surgery of the middle ear. Ann Otol Rhinol Laryngol 1968;77:927-937

Inanlı S, Ozturk O, Batman C, Tutkun A, Uneri C, Sehitoglu MA. Clinical importance of supratubal recess in cholesteatoma surgery. Otol Neurotol 2001;22:754-760

Gocmen H, Kılıc R, Ozdek A, Kızılkaya Z, Safak MA; Samim E. Surgical treatment of cholesteatoma in children. Int J Pediatr Otorhinolaryngol 2003;67:867-872

Derlacki E, Clemis JD. Congenital cholesteatoma of the middle ear and mastoid. Ann Otol Rhinol Laryngol 1965;74:706-725

Sade J, Babiacki A, Pinkus G. The metaplastic and congenital origin of cholesteatoma. Acta Otolaryngol 1983;96:119-129

Ruedi L. Pathogenesis and surgical treatment of the middle ear cholesteatoma. Acta Otolaryngol (Stockh) Suppl 1979;361:1-45

Tseng SCG, Jarvinen MG, Nelson WG, Huang JW, Woodcock-Mitchell J, Sun TT. Correlation of spesific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell 1982;30:361-372

Sun TT, Eichner R, Nelson WG, Tsengf SCG, Weiss RA, Jarvinen M, Woodcock-Mitchell J. Keratin classes: molecular markers for different types of epithelial differentiation. J Invest Dermatol 1983;81:109-115

Eichner R, Sun TT, Aebi U. The role of keratin subfamilies and keratin pairs in the formation of human epidermal intermediate filaments. J Cell Biol 1986;102:1767-1777

Young R, Rowles P. The spatial organization of keratinocytes in acquired middle ear cholesteatoma resembles that of external auditory canal skin and pars flaccida. Acta Otolaryngol 1990;110:115-119

Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 1990;111:567-580

O’Donoghue GM. The migration theory of cholesteatoma formation: some experimental observations. J Laryngol Otol 1986;100:395-398

Broekaert D, Cornille A, Eto E, Leigh I, Ramaekers F, Van Muijen G, Coucke P, De Bersaques J, Kluyskens P, Gillis E. A comparative immunohistochemical analysis of the cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma and in epidermis. Virchows Arch Pathol Anat 1988;413:39-51

Huang CC, Shi GS, Yi ZX. Experimental induction of middle ear cholesteatoma in rats. Am J Otolaryngol 1988;9:165-172

Chao WY, Huang CC. An immunocytochemical study of

cytokeratin expression in human middle ear cholesteatoma. Arch Otorhinolaryngol 1989;246:37-42

Masaki M, Wright CG, Meyerhoff WL. Experimental cholesteatoma: epidermal ingrowth through tympanic membrane following middle ear application of propylene glycol. Acta Otolaryngol 1989;108:113-121

Van Blitterswijk CA, Grote JJ, Lutgert RW, Hesseling SC, Out CJ, Van Muijen GN, Fransen JA. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis. Ann Otol Rhinol Laryngol 1989;98:635-640

Vennix PP, Kuijpers W, Tonnaer E, Peters TA, Ramaekers FC. Cytokeratins in induced epidermoid formation and cholesteatoma lesions. Arch Otolaryngol Head Neck Surg 1990;116:560-565

Broekaert D, Coucke P, Leperque S, Ramaekers F, Van Muijen G, Boedts D, Leigh I, Lane B. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues. Ann Otol Rhinol Laryngol 1992;101:931-938

Buija J, schilling V, Holly A, Stammberger M, Kastanbauer E. Hyperproliferation associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol 1993;113:364-368

Sudhoff H, Bujia J, Borkowshi G, Koc C, Holly A, Hildmann H, Fisseler- Eckhoff A. Basement membrane in middle ear cholesteatoma: immunohistochemical and ultrastructural observations. Ann Otol Rhinol Laryngol 1996;105:804-810

Vennix PP, Kuijpers W, Peters TA, Tonnaer E, Ramaekers F. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes. Arch Otolaryngol Head Neck Surg 1996;122:825-832

Goycoolea MV, Hueb MM, Muchow D, Paparella MM. The theory of the trigger, the bridge and the transmigration in the pathogenesis of acquired cholesteatoma. Acta Otolaryngol 1999;119:244-248

Kim CS, Chung JW. Morphologic and biologic changes of experimentally induced cholesteatoma in Mongolian gerbils with anticytokeratin and lectin study. Am J Otol 1999;20:13-18

Lee RJ, Sidey CM, Narula AA, McKenzie IC, James RFL. Keratin patterns in aural epithelia and cholesteatoma cell culture. In Cholesteatoma and Mastoid Surgery, Proceedings of the Fourth International Conference, Nakano Y (ed), Kugler Publications, Amsterdam / New York, 1993;pp 167-171

Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT.

Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 1982;95:580-588

Sasaki H, Huang CC. Cytokeratin expression in cholesteatoma, meatal skin and tympanic membrane. In: Cholesteatoma and Mastoid Surgery, Proceedings of the Fourth International Conference, Nakano Y (ed), Kugler Publications, Amsterdam / New York, 1993;pp 143-150

Mare DS, Jong DE, Van Erp PEJ, Van de Kerkhof PCM. Markers for proliferation and keratinization in the magrin of the active psoriatic lesion. Br J Dermatol 1990;122:469-475

Ergun S, Zheng X, Carlsöö B. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical study. Acta Otolaryngol 1994;114,295-302

Lepercque S, Broekaert D, Van Cauwenberge P. Cytokeratin expression patterns in the human tympanic membrane and external ear canal. Eur Arch Otorhinolaryngol 1993;250,78-81

Sasaki H, Huang CC. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma. Otolaryngol Head Neck Surg 1994;110:310-317

Olszewska E, Lautermann J, Koc C, Schwaab M, Dazert S, Hildmann H, Sudhoff H. Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma. Eur Arch Otorhinolaryngol 2005;262:731-736

Rosenfeld RM, Moura RL, Bluestone CD. Predictors of residual – recurrent cholesteatoma in children. Arch Otolaryngol Head Neck Surg 1992;118:384-439

Liang JN, Chrobok V, Michaels L, Wright A. Incidence and cytokeratin analysis of the epidermal formation. Registry 2000;8:1-4

Kim HJ, Tinling SP, Chole RA. Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation. J Korean Med Sci 2002;17:381-388

Weiss RA, Eichner R, Sun T. Monoclonal antibody analysis of keratin expression in epidermal disease: a 48- and 56-k Dalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 1984;98:1397-1406

Weiss RA, Guillet GYA, Freedberg IM, Farmer ER, Small EA, Weiss MM, Sun TT. The use of monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining pattern. J Invest Dermatol 1983;81:224-230

Shinkawa H, Hozawa J, Usami S. Immunohistochemical study on CK and vimentin expression in congenital cholesteatoma. In: Nakano Y (ed). Cholesteatoma and Mastoid Surgery. Kugler, Amsterdam, 1993;pp 155-166

Kim HJ, Tinling SP, Chole RA. Expression patterns of

cytokeratins in retraction pocket cholesteatoma. Laryngoscope 2001;111:1032-1036

Olsewska E, Sudhoff H. Comparative cytokeratin distribution patterns in cholesteatoma epithelium. Histol Histopathol 2007;22:37-42

Lifton WB. Epidermal migration in the ear: the location and characteristics of the generation center revealed by utilizing a radio-active desoxyribose nucleic acid precursor. Acta Otolaryngol (Stockh) (Suppl) 1968;240:-39